Free tool
FAERS Monitor: Dextrose 5% and Electrolyte No. 48 In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017484 or its brand name (Dextrose 5% and Electrolyte No. 48 In Plastic Container, Dextrose, Magnesium Chloride, Potassium Chloride, Potassium Phosphate, Monobasic, Sodium Chloride, Sodium Lactate). Reports on generic versions are filed under their own applications.
Reports
3
Serious
3
100% of reports
Hospitalization
3
Death reported
0
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- pneumonia2
- capillary leak syndrome1
- covid-191
- febrile neutropenia1
- respiratory failure1
- sepsis1
- septic shock1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,156 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| capillary leak syndrome | 1 | 3393.6 | 684.5 | 847 |
| septic shock | 1 | 161.2 | 32.5 | 39 |
| febrile neutropenia | 1 | 105.7 | 21.3 | 26 |
| respiratory failure | 1 | 96.1 | 19.4 | 23 |
| sepsis | 1 | 62.9 | 12.7 | 15 |
| pneumonia | 2 | 43.3 | 19.5 | 46 |
| covid-19 | 1 | 40.0 | 8.1 | 9 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.